Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Lotus Tissue Repair raises funds to advance treatment for dystrophic epidermolysis bullosa

July 8, 2011

Novel tyrosine inhibitors for skin disorders disclosed by Galderma

July 4, 2011

Promising preliminary phase IIb data on Anacor's AN-2728 in psoriasis

July 1, 2011

Medivir patents new cathepsin S inhibitors

June 30, 2011

Galderma presents novel peroxide derivatives for acne

June 30, 2011

Meda files MAA with EMA for Zyclara

June 27, 2011

Galderma presents new matrix metalloproteinase inhibitors for rosacea

June 27, 2011

Polyphor prepares novel chemokine CCR10 receptor antagonists

June 20, 2011

Almirall launches Actikerall in U.K. for treatment of actinic keratosis

June 8, 2011

Novel lactam tachykinin receptor antagonists presented

June 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...